Fluidigm Corporation logo
Fluidigm Corporation FLDM

Fluidigm Corporation Net Debt 2011-2025 | FLDM

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Fluidigm Corporation

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-5.38 M 69.1 M 76.7 M 142 M 184 M 232 M 243 M -35.3 M -58.6 M -3.42 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
243 M -58.6 M 84.5 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Diagnostics research industry

Issuer Net Debt Price % 24h Market Cap Country
Brainsway Ltd. Brainsway Ltd.
BWAY
-6.88 M $ 17.13 1.66 % $ 99.4 M israelIsrael
Centogene N.V. Centogene N.V.
CNTG
1.18 M - -6.23 % $ 30.6 M germanyGermany
DarioHealth Corp. DarioHealth Corp.
DRIO
-12.1 M $ 12.15 2.14 % $ 345 M israelIsrael
DexCom DexCom
DXCM
-487 M $ 66.06 -1.34 % $ 25.5 B usaUSA
Akumin Akumin
AKU
1.21 B - -17.87 % $ 25.9 M canadaCanada
Exact Sciences Corporation Exact Sciences Corporation
EXAS
-560 M $ 101.57 0.07 % $ 18.8 B usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
-76 M $ 16.0 1.59 % $ 172 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-33.3 M - -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
-11.2 M - -13.05 % $ 7.29 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
-2.64 M $ 1.56 -3.7 % $ 1.98 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
-173 M - - $ 562 M britainBritain
Castle Biosciences Castle Biosciences
CSTL
-108 M $ 38.95 0.82 % $ 1.08 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
-17.2 M - 0.22 % $ 16.8 M usaUSA
Danaher Corporation Danaher Corporation
DHR
13.6 B $ 227.29 0.42 % $ 166 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
-53.3 M $ 26.94 -0.74 % $ 815 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
-6.07 B - - $ 399 M chinaChina
Mettler-Toledo International Mettler-Toledo International
MTD
1.8 B $ 1 408.65 1.08 % $ 29.9 B schweizSchweiz
Genetic Technologies Limited Genetic Technologies Limited
GENE
-11.1 M - - $ 7.1 B australiaAustralia
NeoGenomics NeoGenomics
NEO
-23.3 M $ 12.15 2.53 % $ 1.54 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
751 M $ 6.84 -0.36 % $ 1.48 B usaUSA
Genetron Holdings Limited Genetron Holdings Limited
GTH
-1.35 B - 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
-33.6 M - -11.32 % $ 2.94 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
769 M - - $ 10.7 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
-48 M $ 19.9 -3.21 % $ 1.07 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
-139 M $ 2.12 - $ 538 M usaUSA
Celcuity Celcuity
CELC
82.8 M $ 101.74 -3.33 % $ 4.01 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
-51.3 M - -8.98 % $ 14.8 K usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
-1.04 M $ 3.35 -6.42 % $ 107 K usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
2.48 B $ 26.46 -0.62 % $ 20 B niderlandNiderland
Co-Diagnostics Co-Diagnostics
CODX
-11.9 M $ 0.3 -13.39 % $ 8.8 M usaUSA
Precipio Precipio
PRPO
-1.18 M $ 24.67 -1.2 % $ 32 M usaUSA
Quidel Corporation Quidel Corporation
QDEL
-377 M $ 28.82 0.07 % $ 1.21 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
11.2 B $ 224.13 0.84 % $ 40.6 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
1.31 B $ 45.14 -0.21 % $ 10 B niderlandNiderland
Guardant Health Guardant Health
GH
646 M $ 103.55 1.45 % $ 12.7 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
-10.9 M - -6.19 % $ 10.5 M usaUSA
Sotera Health Company Sotera Health Company
SHC
1.94 B $ 16.76 -0.42 % $ 4.74 B usaUSA
Soleno Therapeutics Soleno Therapeutics
SLNO
-20.8 M $ 49.79 -4.25 % $ 2 B usaUSA
Heska Corporation Heska Corporation
HSKA
-153 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
-11.2 M - -20.0 % $ 1.06 M usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
27.3 B $ 574.27 0.46 % $ 219 B usaUSA
Illumina Illumina
ILMN
-494 M $ 134.66 -0.16 % $ 21.4 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
2.1 B $ 197.59 2.36 % $ 10.2 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
55.4 M $ 0.96 -10.6 % $ 61.9 M irlandaIrlanda
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
-107 M $ 31.39 1.47 % $ 1.88 B usaUSA
Quotient Limited Quotient Limited
QTNT
103 M - -11.32 % $ 1.1 M schweizSchweiz
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
5.24 B $ 184.04 0.81 % $ 20.4 B usaUSA
Biodesix Biodesix
BDSX
14.5 M $ 7.63 -2.8 % $ 989 M usaUSA
Myriad Genetics Myriad Genetics
MYGN
115 M $ 7.07 -2.01 % $ 641 M usaUSA